Senior insider sale
General Counsel at ROCKET PHARMACEUTICALS, INC. — senior position signals high conviction
$57.3K
16.99K shares
What this filing means
WILSON MARTIN plans to sell 16.99K shares of ROCKET PHARMACEUTICALS, INC. valued at approximately $57.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/13/2026ACC: 0001959173-26-003570
Officer· General Counsel
Since Dec 2021
16.99K
Shares to sell
$57.3K
Approx. market value
3.36K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/11/2026
3.36KTotal acquired3.36K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/11/2026 | Restricted Stock Vesting Compensation | 3.36K | — |
| Total | 3.36K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.38K
Market value
$4.6K
2/18/2026
—Completed
Units to sell
12.25K
Market value
$40.6K
2/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.36K
Market value
$12.1K
5/13/2026
Total
Units
16.99K
Value
$57.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/18/2026 | 1.38K | $4.6K | — | Completed |
2/13/2026 | 12.25K | $40.6K | — | Completed |
| Planned — Approximate Date | ||||
5/13/2026 | 3.36K | $12.1K | NASDAQ | Planned |
| Total | 16.99K | $57.3K | ||